CAS: 82-46-2; 1,5-Dichloroanthraquinone

上下游产品

CAS号117-14-6 蒽醌-1,5-二磺酸 | CAS号82-35-9 1,5-二硝基蒽醌 | CAS号36003-92-6 9,10-Dihydro-9,... | CAS号82-48-4 1,8-Anthracened... | CAS号82-49-5 1-蒽醌磺酸 | CAS号84-65-1 蒽醌 | CAS号82843-46-7 1,5,9-trichloro... | CAS号855952-61-3 9,10-dibromo-1,... | CAS号6406-96-8 1,5-Dichloroant... | CAS号7719-09-7 氧氯化硫 | CAS号602-77-7 1,5-二溴蒽醌 | CAS号10430-72-5 1-Chloro-5-brom... | CAS号3278-82-8 1,5-二溴蒽 | CAS号201-88-7 anthra[10,4-cd:... | CAS号197-61-5 玉红省 | CAS号2944-16-3 1,5-bis(4-metho... | CAS号82-38-2 1-(甲氨基)蒽醌 | CAS号81-58-3 1,4,5,8-四氯蒽醌 | CAS号129-43-1 1-羟基蒽醌

1-蒽醌磺酸置于盐酸,Sodium Chlorate,硫酸,汞,Mercury(II) Oxide体系中,化学反应生成 1,5-二氯蒽醌
参考文献:Fierz-David,H.E.,Helvetica Chimica Acta,1927,Vol. 10,P. 199
标题:Fierz-David,H.E.,Helvetica Chimica Acta,1927,Vol. 10,P. 199

专利信息

专利号:US-6596774-B1
优先权日:2001-09-27
标题:Synthesis, lipid peroxidation and cytotoxic evaluation of 10-substituted 1,5-dichloro-9(10H)-anthracenone derivatives
发明人：HUANG HSU-SHAN
摘要:The present invention is the synthesis of a series of 1,5-dichloro-9(10H)-anthracenones bearing O-linked and N-linked substituents in the 10-position. These compounds were evaluated for their ability to inhibit the growth of the human oral epidermoid carcinoma cells (KB cell line), human cervical carcinoma cells of ME 180 (GBM 8401) and Chinese hamster ovary cells (CHO), respectively. In addition, redox property of the compounds for inhibition of lipid peroxidation in model membranes was determined.

专利号:US-4211726-A
优先权日:1979-02-16
标题:Synthesis of substituted 9,10-anthracene-dicarboxaldehydes and 9,10-dihydro-9,10-anthracenedicarboxaldehydes
发明人：LANG STANLEY A JR; LIN YANG-I
权利人:AMERICAN CYANAMID CO
摘要:There is provided a process for the manufacture of substituted 9,10-anthracenedicarboxaldehydes and substituted 9,10-dihydro-9,10-anthracenedicarboxaldehydes useful as intermediates in the preparation of antibacterial agents.

专利号:US-4255342-A
优先权日:1979-04-02
标 题:Synthesis of phenoxyanthraquinones
发明人：OLIN ARTHUR D
权利人:TOMS RIVER CHEMICAL CORP
摘要:A method of synthesizing phenoxyanthraquinones in the absence of excess phenol, water-miscible alcohols or polar aprotic solvents. Phenoxyanthraquinones are synthesized in high yield and purity by treatment of the corresponding chloro- or nitroanthraquinone with an equivalent of alkali metal phenoxide, particularly potassium phenoxide in a liquid aromatic solvent which is a chloro-substituted benzene, a lower alkyl-substituted benzene, or a loweralkyl-chloro-substituted benzene. The use of the inventive solvents results in high yields of readily isolable, substantially pure product. The used solvent is readily recoverable without the pollution potential of excess phenol or difficultly recoverable water-miscible solvents.

专利号:US-2005009924-A1
优先权日:2003-07-08
标 题 :Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives
发明人：HUANG HSU-SHAN
摘要:This invention relates to novel anthraquinone compounds useful in the treatment of allergic, inflammatory conditions, antioxidant, tumor condition, stem cell application, tissue engineering, applied in treating age-associate tissue degeneration, reverse organ failure in chronic high-turnover disease and therapeutic compositions containing such compounds. The compounds of the present invention are 1,4-, 1,5- and 1,8-difunctionalized anthraquinones or analogs thereof. According to the practice of the invention, there are provided bis-symmetrical substituted anthraquinone compounds according to formula I: n n nwherein R1, R2, R3 and R4 present a straight, aminoalkylamino side chains or branched chain alkyl group having 1 to 6 carbons which may be substituted with one or more groups of R5, or R1, R2, R3 and R4 present phenyl or benzyl which may be substituted with one or two groups of R6; wherein R5 is selected from the group consisting of halogen, —RNH 2 , —RNH 2 R, —ROH, —NO 2 , —OCH 3 , —OCH 2 CH 3 , and —OCH 2 CH 2 CH 3 ; and wherein R6 is selected from the group consisting of a straight or branched chain alkyl group having 1 to 4 carbons, halogen, —RNH 2 , —RNH 2 R, —ROH, —NO 2 , —OCH 3 , —OCH 2 CH 3 , —OCH 2 CH 2 CH 3 , —CH 2 Br, —CH 2 Cl, —CH 2 OH, —C(CH 3 ) 3 , —(CH 2 ) 2 0H, —(CH 2 ) 3 OH, —(CH 2 ) 4 OH, —CH 2 NH 2 , —(CH 2 ) 2 NH 2 , —(CH 2 ) 3 NH 2 , —(CH 2 ) 4 NH 2 , —(CH 2 ) 5 NH 2 , —CH 2 N(CH 3 ) 2 , —(CH 2 ) 2 N(CH 3 ) 2 , —(CH 2 ) 2 NH(CH 2 ) 2 OH, —(CH 2 ) 3 NH(CH 2 ) 2 OH, —(CH 2 ) 2 NHCH 2 OH, —(CH 2 ) 3 NHCH 2 OH, —CH 2 CH(CH 3 ) 2 , —CHCl 2 , —CH(CH 3 )Cl, —(CH 2 ) 2 Cl, —(CH 2 ) 3 Cl, —(CH 2 ) 3 Br, —(CH 2 ) 4 Br, and —(CH 2 ) 4 Cl. n n Chart 1. Activation of hTERT promoter-driven SEAP expression by c-Myc. About 1×10 7 hTERT-BJ1 cells were transfected with 13.5 μg each of plasmid pSEAP or pPhTERT-SEAP and of plasmid pMT2T or pMT2T-cMyc by electroporation. After 24 h, viable cells were harvested, and reinoculated at a density of 3×10 5 /mL, and the SEAP activity after 24 h at 37 â–¡. The transfection efficiency of each experiment was determined by cotransfection with 1.5 μg of plasmid pCMVβ. The values were determined from three experiments. P<0.05 is presented by an asterisk.

专利号:US-9917260-B2
优先权日:2013-08-23
标题 :Compounds with terminal heteroarylcyanovinylene groups and their use in organic solar cells
发明人：SUNDARRAJ SUDHAKAR; EICKHOFF CHRISTIAN; BAHULAYAN SHEEJA; SEND ROBERT; NISHIMAE YUICHI; REICHELT HELMUT; TANABE JUNICHI; ERK PETER
权利人:BASF SE
摘要:The present invention relates to a photoactive material comprising a donor substance and an acceptor substance, wherein the donor substance comprises or consists of one or more compounds of formula (I) described herein, or the acceptor substance comprises or consists of one or more compounds of formula (I) described herein, or the donor substance comprises or consists of a first compound of formula (I) described herein and the acceptor substance comprises a second compound of formula (I) described herein with the proviso that the first and second compound are not the same, as well as to an organic solar cell comprising said photoactive material. The present invention also relates to a photoelectric conversion device comprising or consisting of two or more organic solar cells comprising said photoactive material and to compounds of formula (I) as described herein for use as donor substance or as acceptor substance in a photoactive material, Further, the present invention relates to the use of a compound of formula (III) as described herein in the synthesis of a compound of formula (I)as described herein.

专利号:US-6369246-B2
优先权日:1999-04-14
标题 :Synthesis and pharmaceuticals of novel 9-substituted-1, 5-dichloroanthracene analogs
发明人：HUANG HSU-SHAN; LEE KUNG-YUAN; SHI CHANG-HSIN; HSU HSIEN-CHIN
权利人:KEITH CHAN GLOBOASIA LLC DR
摘要:The invention relates to novel anthracene compounds useful in the treatment of allergic, inflammatory conditions, tumor conditions and therapeutic compositions containing such compounds. The compounds of the present invention are 9-acyloxy-substituted 1,5-dichloroanthracene or analogs thereof. According to the practice of the invention, there are provided 9-acyloxy substituted 1,5-dichloroanthracene compounds according to formula III:wherein R represents a straight or branched chain alkyl group having 1 to 6 carbons which may be substituted with one or more groups of R1, or R represents phenyl or benzyl which may be substituted with one or two groups of R2; wherein R1 is selected from the group consisting of halogen, -NO2, -OCH3, OCH2CH3, and -OCH2CH2CH3; and wherein R2 is selected from the group consisting of a straight or branched chain alkyl group having 1 to 4 carbons, halogen, -NO2, -OCH3, -OCH2CH3, and -OCH2CH2CH3.